Follicle-Stimulating Hormone Exacerbates Cardiovascular Disease in the Presence of Low or Castrate Testosterone Levels

被引：6
|
作者：
Duivenvoorden, Wilhelmina C. M. [1 ,2 ]
Margel, David [3 ,4 ]
Gayathri, Vishal Subramony [2 ]
Duceppe, Emmanuelle [5 ,6 ,7 ]
Yousef, Sadiya [2 ]
Naeim, Magda [2 ]
Khajehei, Mohammad [1 ]
Hopmans, Sarah [1 ]
Popovic, Snezana [8 ]
Ber, Yaara [3 ]
Heels-Ansdell, Diane [9 ]
Devereaux, Philip J. [5 ,6 ,7 ]
Pinthus, Jehonathan H. [1 ,2 ,10 ]
机构：
[1] McMaster Univ, Fac Med, Dept Surg, Div Urol, Hamilton, ON, Canada
[2] Res Inst St Joes Hamilton, Hamilton, ON, Canada
[3] Rabin Med Ctr, Dept Urol, Petah Tiqwa, Israel
[4] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[5] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada
[6] Hamilton Hlth Sci, Hamilton, ON, Canada
[7] Ctr Hosp Univ Montreal, Dept Med, Montreal, PQ, Canada
[8] McMaster Univ, Fac Med, Dept Pathol & Mol Med, Hamilton, ON, Canada
[9] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[10] McMaster Univ, Dept Surg Oncol Urooncol, 699 Concess St, Hamilton, ON L8V 5C2, Canada
来源：
JACC-BASIC TO TRANSLATIONAL SCIENCE | 2024年 / 9卷 / 03期
关键词：
androgen-deprivation therapy; cardiovascular disease; follicle- stimulating hormone; GnRH-antagonist; prostate cancer; ANDROGEN-DEPRIVATION THERAPY; MYOCARDIAL INJURY; HOMEOSTATIC CHEMOKINES; NONCARDIAC SURGERY; 30-DAY MORTALITY; PROSTATE-CANCER; TROPONIN LEVELS; ATHEROSCLEROSIS; RISK; MEN;
D O I：
10.1016/j.jacbts.2023.10.010
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Low testosterone (T), common in aging men, associates with cardiovascular disease. We investigated whether follicle -stimulating hormone (FSH), which is affected by T, modulates the cardiovascular effects associated with low T or castration. FSH b -/- :low-density lipoprotein receptor (LDLR) -/- mice, untreated or castrated (orchiectomy, gonadotropin-releasing hormone agonist or antagonist), demonstrated signi ficantly less atherogenesis compared with similarly treated LDLR -/- mice, but not following FSH delivery. Smaller plaque burden in LDLR -/- mice receiving gonadotropin-releasing hormone antagonists vs agonists were nulli fied in FSH b -/- :LDLR -/- mice. Atherosclerotic and necrotic plaque size and macrophage in filtration correlated with serum FSH/T. In patients with prostate cancer, FSH/T following androgen -deprivation therapy initiation predicted cardiovascular events. FSH facilitates cardiovascular disease when T is low or eliminated. (J Am Coll Cardiol Basic Trans Science 2024;9:364 -379) (c) 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY -NC -ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码：364 / 379
页数：16
相关论文
共 50 条
  • [31] Follicle-stimulating hormone receptors in oocytes?
    Méduri, G
    Charnaux, N
    Driancourt, MA
    Combettes, L
    Granet, P
    Vannier, B
    Lossfelt, H
    Milgrom, E
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (05): : 2266 - 2276
  • [32] Effects of exogenous testosterone on testicular luteinizing hormone and follicle-stimulating hormone receptors during aging
    Ottinger, MA
    Kubakawa, K
    Kikuchi, M
    Thompson, N
    Ishii, S
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2002, 227 (09) : 830 - 836
  • [33] RADIORECEPTOR ASSAY FOR FOLLICLE-STIMULATING HORMONE
    CHENG, KW
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1975, 41 (03): : 581 - 589
  • [34] ORAL CONTRACEPTIVES AND FOLLICLE-STIMULATING HORMONE
    CARGILLE, CM
    ROSS, GT
    LANCET, 1968, 1 (7548): : 924 - &
  • [35] Role of Follicle-Stimulating Hormone in Spermatogenesis
    Oduwole, Olayiwola O.
    Peltoketo, Hellevi
    Huhtaniemi, Ilpo T.
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [36] Regulation of follicle-stimulating hormone receptor
    Minegishi, T
    Tano, M
    Nakamura, K
    Nakamura, M
    Igarashi, S
    Ito, I
    Shinozaki, H
    Karino, S
    Ibuki, Y
    Miyamoto, K
    HORMONE RESEARCH, 1996, 46 : 37 - 44
  • [37] Efficacy of recombinant follicle-stimulating hormone
    Quinton, R
    Bouloux, PMG
    Illingworth, JM
    Martineau, I
    Loumaye, E
    FERTILITY AND STERILITY, 1996, 66 (01) : 164 - 164
  • [38] THE CONSUMPTION OF FOLLICLE-STIMULATING HORMONE BY THE OVARIES
    GANS, P
    ACTA PHYSIOLOGICA ET PHARMACOLOGICA NEERLANDICA, 1950, 1 (02): : 279 - 287
  • [39] ORAL CONTRACEPTIVES AND FOLLICLE-STIMULATING HORMONE
    SCHMIDTE.H
    KOPERA, H
    LANCET, 1968, 1 (7553): : 1194 - &
  • [40] Extragonadal Effects of Follicle-Stimulating Hormone on Osteoporosis and Cardiovascular Disease in Women during Menopausal Transition
    Zhu, Dongxing
    Li, Xiaosa
    Macrae, Vicky E.
    Simoncini, Tommaso
    Fu, Xiaodong
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2018, 29 (08): : 571 - 580
12345